Yoshiki Seino

Osaka, 5530003, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Intracranial aneurysm as a possible complication of osteogenesis imperfecta: a case series and literature review.

Intracranial aneurysm as a possible complication of osteogenesis imperfecta: a case series and literature review.

Journal: Endocrine journal
Published: May 10, 2023

Self-Administration of Burosumab in Children and Adults with X-Linked Hypophosphataemia in Two Open-Label, Single-Arm Clinical Studies.

Self-Administration of Burosumab in Children and Adults with X-Linked Hypophosphataemia in Two Open-Label, Single-Arm Clinical Studies.

Journal: Advances in therapy
Published: October 28, 2022

Safety and Efficacy of Burosumab in Pediatric Patients With X-Linked Hypophosphatemia: A Phase 3/4 Open-Label Trial.

Safety and Efficacy of Burosumab in Pediatric Patients With X-Linked Hypophosphatemia: A Phase 3/4 Open-Label Trial.

Journal: Journal of the Endocrine Society
Published: December 22, 2021

Clinical performance of a novel chemiluminescent enzyme immunoassay for FGF23.

Clinical performance of a novel chemiluminescent enzyme immunoassay for FGF23.

Journal: Journal of bone and mineral metabolism
Published: May 16, 2021

Switching from conventional therapy to burosumab injection has the potential to prevent nephrocalcinosis in patients with X-linked hypophosphatemic rickets.

Switching from conventional therapy to burosumab injection has the potential to prevent nephrocalcinosis in patients with X-linked hypophosphatemic rickets.

Journal: Journal of pediatric endocrinology & metabolism : JPEM
Published: December 23, 2020

Interim Analysis of a Phase 2 Open-Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor-Induced Osteomalacia.

Interim Analysis of a Phase 2 Open-Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor-Induced Osteomalacia.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: May 27, 2020

Monthly intravenous alendronate treatment can maintain bone strength in osteogenesis imperfecta patients following cyclical pamidronate treatment.

Monthly intravenous alendronate treatment can maintain bone strength in osteogenesis imperfecta patients following cyclical pamidronate treatment.

Journal: Journal of pediatric endocrinology & metabolism : JPEM
Published: February 17, 2020

Efficacy and safety of growth hormone treatment in Japanese children with small-for-gestational-age short stature in accordance with Japanese guidelines.

Efficacy and safety of growth hormone treatment in Japanese children with small-for-gestational-age short stature in accordance with Japanese guidelines.

Journal: Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology
Published: July 08, 2018

Responses to the Letter to the Editor "Does growth-hormone treatment affect patients with and without a mitochondrial disorder differentially ?" (Vol. 27, No. 2, p. 107-108, 2018).

Responses to the Letter to the Editor "Does growth-hormone treatment affect patients with and without a mitochondrial disorder differentially ?" (Vol. 27, No. 2, p. 107-108, 2018).

Journal: Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology
Published: June 08, 2018

First-in-Asian Phase I Study of the Anti-Fibroblast Growth Factor 23 Monoclonal Antibody, Burosumab: Safety and Pharmacodynamics in Adults With X-linked Hypophosphatemia.

First-in-Asian Phase I Study of the Anti-Fibroblast Growth Factor 23 Monoclonal Antibody, Burosumab: Safety and Pharmacodynamics in Adults With X-linked Hypophosphatemia.

Journal: JBMR plus
Published: May 31, 2018

A case of perinatal hypophosphatasia with a novel mutation in the ALPL gene: clinical course and review of the literature.

A case of perinatal hypophosphatasia with a novel mutation in the ALPL gene: clinical course and review of the literature.

Journal: Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology
Published: January 05, 2018

Incidence of diabetes mellitus and neoplasia in Japanese short-statured children treated with growth hormone in the Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS).

Incidence of diabetes mellitus and neoplasia in Japanese short-statured children treated with growth hormone in the Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS).

Journal: Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology
Published: March 13, 2017
Showing 1-12 of 23

Last Updated: 09/26/2026